Hormonaly

About Hormonaly

Hormonaly.ai is a clinical AI company building the intelligence layer for hormone, peptide, and regenerative medicine. The platform deploys 24 specialized agents that synthesize GRADE-rated answers from over 10,000 PubMed studies in under 100 milliseconds — delivering evidence-grounded clinical decision support at the point of care. Coverage spans therapeutic and wellness peptides including BPC-157, tesamorelin, sermorelin, kisspeptin, hCG, oxytocin, thymosin alpha, cerebrolysin, retatrutide, and GLP-1 analogues, with full bilingual (English/Arabic) support for globally scalable deployment. 🔬 WHO WE SERVE Clinicians, endocrinologists, longevity physicians, compounding pharmacies, telehealth platforms, and health tech companies that need defensible, citation-backed evidence synthesis for prescribing decisions in a rapidly evolving regulatory environment. 🚀 ENTERPRISE API The Hormonaly API is now open to enterprise buyers — enabling health systems, digital health companies, and compounding pharmacies to integrate evidence-based AI directly into their clinical workflows. 🏆 CREDENTIALS & PARTNERSHIPS • Founded by Fady Hannah-Shmouni, MD FRCPC — board-certified endocrinologist, biochemical geneticist, NIH-funded researcher, 100+ peer-reviewed publications (h-index 28), Assistant Clinical Professor at UBC • Member: NVIDIA Inception Program & Google for Startups • Academic research partnerships in precision medicine • Active in Canada and the United States